Growing community of inventors

Mason, OH, United States of America

Jane Far-Jine Djung

Average Co-Inventor Count = 5.37

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 37

Jane Far-Jine DjungBiswanath De (6 patents)Jane Far-Jine DjungMichael Philip Clark (6 patents)Jane Far-Jine DjungMichael G Natchus (4 patents)Jane Far-Jine DjungMatthew John Laufersweiler (4 patents)Jane Far-Jine DjungJoshua Spector Tullis (2 patents)Jane Far-Jine DjungSteven Karl Laughlin (2 patents)Jane Far-Jine DjungAdam Golebiowski (1 patent)Jane Far-Jine DjungTodd Andrew Brugel (1 patent)Jane Far-Jine DjungCynthia Monesa Crago Clark (1 patent)Jane Far-Jine DjungJane Far-Jine Djung (6 patents)Biswanath DeBiswanath De (59 patents)Michael Philip ClarkMichael Philip Clark (18 patents)Michael G NatchusMichael G Natchus (53 patents)Matthew John LaufersweilerMatthew John Laufersweiler (8 patents)Joshua Spector TullisJoshua Spector Tullis (4 patents)Steven Karl LaughlinSteven Karl Laughlin (4 patents)Adam GolebiowskiAdam Golebiowski (9 patents)Todd Andrew BrugelTodd Andrew Brugel (7 patents)Cynthia Monesa Crago ClarkCynthia Monesa Crago Clark (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The Procter Gamble Company (6 from 17,164 patents)


6 patents:

1. 6919346 - Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity

2. 6821971 - Fused pyrazolone compounds which inhibit the release of inflammatory cytokines

3. 6790846 - Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity

4. 6730668 - 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

5. 6677337 - 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines

6. 6566357 - Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…